AbbVie | ABBV - Ordinary Share Capital

Stock Price
211.82
Daily Change
-13.84 -6.13%
Monthly
-3.80%
Yearly
10.47%
Q1 Forecast
216.14

AbbVie reported $1.77B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Abbott USD 1.74B 23.39B Sep/2025
ALKERMES USD 165.1M 49K Sep/2025
Amgen USD 538M 300K Sep/2025
AstraZeneca USD 1.55B 1.16B Sep/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Eisai JPY 282.12M 0 Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Gilead Sciences USD 1.24B 0 Sep/2025
GlaxoSmithKline GBP 4.03B 119.13M Sep/2025
J&J USD 2.41B 584K Sep/2025
Medtronic USD 1.28B 66K Jun/2025
Merck USD 2.49B 15.79M Sep/2025
Neurocrine Biosciences USD 99.7M 700K Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 0 Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
UCB EUR 584M 0 Dec/2024
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
United Therapeutics USD 42.9M 42.1M Sep/2025
Vertex Pharmaceuticals USD 254M 2.29M Sep/2025
Zoetis USD 441.46M 2.48M Sep/2025